cells . polyneuropathy on duodenal endocrine Impact of familial amyloid associated

M. El-Salhy,R. Stenling,E. Wilander,L. Grimelius

Abstract:Duodenal endocrine cells in 11 patients with familial amyloid associated polyneuropathy (FAP) were compared with those in 12 healthy volunteers by means of immunohistochemistry and morphometry. The total endocrine cell content, determined by the argyrophilic reaction and chromogranin A immunoreactivity, was significantly reduced in FAP patients compared with controls. There was a significant reduction in the serotonin, cholecystokinin/gastrin, and secretin immunoreactive cell content. A decreased cell content was also noted for somatostatin and gastric inhibitory polypeptide immunoreactive cells but this was not statistically significant. Amyloid deposits were noted in seven of the 11 biopsy specimens from FAP patients, but otherwise the duodenum was histologically normal in both groups. The reduction in endocrine cell content was not correlated with the degree of amyloid deposit in the duodenum. These findings indicate that patients with FAP have reduced intestinal endocrine cells. This does not seem to be related to amyloid deposits in the mucosa or to villous or crypt abnormalities. The observed changes in endocrine cells may contribute to the development of intestinal motility dysfunction and maldigestion in these patients. (Gut 1994; 35: 1413-1418) Instances of severe constipation, sometimes accompanied by nausea and vomiting, are often the initial gastrointestinal symptoms. With time the constipation is relieved by bouts of diarrhoea that subsequently become continuous 11 12 The course of the disease is steadily progressive, and life expectancy has been reported from Sweden to be approximately nine years from the onset of the symptoms.9 The cause of death is usually intercurrent infection and extreme malnutrition.11 As most transthyretin is produced by the liver,13 liver transplant has been performed, with encouraging results so far, on patients with FAP-met30 mutation and steadily progressive disease.'3 14 Intestinal neuroendocrine peptides have a central role in the regulation of gastrointestinal motility, secretion, and ion transport.'5-17 Several different modes of action have been described for these that is, as paracrine/ endocrine hormones, neurotransmitters, and neuromodulators.'8 Since severe gastrointestinal disturbance in both motility and absorption are common in FAP, it is possible that the neuroendocrine system is affected in these patients. This study aimed to investigate the endocrine cells in the duodenum of FAP patients and to compare the findings with those in healthy controls. The duodenum was chosen because it contains a large number and variety of endocrine cells.19 Gastroenterology Unit, Departnents of Medicine and Pathology, University Hospital, Umei, Sweden M El-Salhy